Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?
Event:
ESC Congress 2016
Topic:
Acute pulmonary embolism
Session:
Optimizing the treatment of pulmonary embolism
